JNGLX
Price
$65.97
Change
+$0.10 (+0.15%)
Updated
Jun 30 closing price
Net Assets
4.35B
LYFCX
Price
$11.90
Change
+$0.02 (+0.17%)
Updated
Jun 30 closing price
Net Assets
34.6M
Interact to see
Advertisement

JNGLX vs LYFCX

Header iconJNGLX vs LYFCX Comparison
Open Charts JNGLX vs LYFCXBanner chart's image
Janus Henderson Global Life Sciences D
Price$65.97
Change+$0.10 (+0.15%)
VolumeN/A
Net Assets4.35B
AlphaCentric Life Sciences & Hlthcare C
Price$11.90
Change+$0.02 (+0.17%)
VolumeN/A
Net Assets34.6M
JNGLX vs LYFCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
JNGLX vs. LYFCX commentary
Jul 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JNGLX is a Hold and LYFCX is a StrongSell.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JNGLX has more cash in the bank: 4.35B vs. LYFCX (34.6M). LYFCX pays higher dividends than JNGLX: LYFCX (1.21) vs JNGLX (0.36). JNGLX was incepted earlier than LYFCX: JNGLX (27 years) vs LYFCX (6 years). LYFCX (2.66) is less costly to investors than JNGLX (0.80). LYFCX is a more actively managed with annual turnover of: 164.00 vs. JNGLX (35.00). JNGLX (2500) and LYFCX (2500) have matching initial minimum investment requirements. LYFCX annual gain was more profitable for investors over the last year : 1.38 vs. JNGLX (-13.61). LYFCX return over 5 years is better than : 6.22 vs. JNGLX (4.83).
JNGLXLYFCXJNGLX / LYFCX
Total Expense Ratio0.802.4133%
Annual Report Gross Expense Ratio0.802.6630%
Fund Existence27 years6 years-
Gain YTD-2.975-3.41587%
Front LoadN/AN/A-
Min. Initial Investment25002500100%
Min. Initial Investment IRAN/AN/A-
Net Assets4.35B34.6M12,572%
Annual Yield % from dividends0.361.2130%
Returns for 1 year-13.611.38-987%
Returns for 3 years8.860.95929%
Returns for 5 years4.836.2278%
Returns for 10 years10.35N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PRWAX78.26N/A
N/A
T. Rowe Price All-Cap Opportunities Fund
IVGTX16.56N/A
N/A
VY® Morgan Stanley Global Franchise S
BIALX29.92N/A
N/A
Brown Advisory Global Leaders Investor
FSSGX11.69N/A
N/A
Fidelity SAI Sustainable Em Markets Eq
NSVAX13.30N/A
N/A
Columbia Small Cap Value II Inst